-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-04-12
Values as of: 2025-04-12
The investment seeks to provide investment returns that closely correspond to the price and yield performance of the Nasdaq Composite Index?. The fund normally invests at least 80% of assets in common stocks included in the index. It uses statistical sampling techniques that take into account such factors as capitalization, industry exposures, dividend yield, price/earnings (P/E) ratio, price/book (P/B) ratio, and earnings growth to create a portfolio of securities listed in the Nasdaq Composite Index that have a similar investment profile to the entire index.
Company Website : www.fidelity.com
Currency: USD
Country : USA
Inception Date: 21/10/2013
Primary Benchmark: MSCI USA IMI/Financials GR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 0.12%
Management Expense Ratio: 0.08 %
N/A
N/A
Symbol | Company Name | Allocation |
---|---|---|
CVE | Cenovus Energy Inc | 7.52 % |
EMMA | Emmaus Life Sciences Inc | 5.65 % |
ABL | Abacus Life Inc. | 3.57 % |
N/A
N/A
Symbol | Name | Mer | Price(Change) | Market Cap |
---|---|---|---|---|
XLF | Financial Select Sector SPDR®.. | 0.13 % |
+0.48 (+1.03%) |
USD 46.97B |
VFH | Vanguard Financials Index Fund.. | 0.10 % |
+1.31 (+1.18%) |
USD 11.40B |
FXO | First Trust Financials AlphaDE.. | 0.63 % |
+0.76 (+1.58%) |
USD 1.87B |
BIZD | VanEck BDC Income ETF | 0.41 % |
+0.29 (+2.00%) |
USD 1.46B |
VPC | Virtus Private Credit ETF | 0.00 % |
+0.32 (+1.68%) |
USD 0.07B |
BDCZ | UBS AG London Branch ELKS 4 | 0.00 % |
+0.23 (+1.42%) |
USD 0.02B |
IYF | iShares U.S. Financials ETF | 0.42 % |
+1.32 (+1.26%) |
N/A |
IAI | iShares U.S. Broker-Dealers & .. | 0.42 % |
+1.69 (+1.28%) |
N/A |
IYG | iShares U.S. Financial Service.. | 0.42 % |
+0.78 (+1.06%) |
N/A |
IAK | iShares U.S. Insurance ETF | 0.43 % |
+2.14 (+1.66%) |
N/A |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
JMBS | Janus Henderson Mortgage-.. | 0.52 % | 0.35 % |
+0.28 (+0%) |
USD 5.13B |
JAGG | 0.00 % | 0.07 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Financial) | Market Performance vs. Exchange (NYSE Arca) | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -5.79% | 65% | D | 53% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -5.79% | 65% | D | 50% | F | ||
Trailing 12 Months | |||||||
Capital Gain | 14.82% | 59% | D- | 86% | B+ | ||
Dividend Return | 0.91% | 24% | F | 18% | F | ||
Total Return | 15.73% | 59% | D- | 85% | B | ||
Trailing 5 Years | |||||||
Capital Gain | 103.46% | 65% | D | 79% | B- | ||
Dividend Return | 14.27% | 35% | F | 36% | F | ||
Total Return | 117.73% | 59% | D- | 77% | C+ | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 16.77% | 71% | C- | 79% | B- | ||
Dividend Return | 18.68% | 71% | C- | 79% | B- | ||
Total Return | 1.91% | 53% | F | 45% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 25.26% | 53% | F | 40% | F | ||
Risk Adjusted Return | 73.96% | 53% | F | 83% | B | ||
Market Capitalization | 0.38B | 71% | C- | 68% | D+ |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.